Jill E. Clampit
Impact in
- Toxicology top 5%
-
- Galectins and Cancer Biology
Papers in
-
- Protein Tyrosine Phosphatases 8
- Metabolism, Diabetes, and Cancer 4
- Melanoma and MAPK Pathways 3
-
- Galectins and Cancer Biology 4
- Co-authors
- Cristina M. Rondinone (9 shared papers)James M. Trevillyan (12 shared papers)Rebecca J. Gum (8 shared papers)Michael R. Jirousek (6 shared papers)Bradley A. Zinker (5 shared papers)Roger G. Ulrich (3 shared papers)Leigh Frost (3 shared papers)Paul Kroeger (3 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (3 papers)Biochemical and Biophysical Research Communications (3 papers)Diabetes (2 papers)SLAS DISCOVERY (1 paper)Endocrinology (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Jill E. Clampit
14 papers receiving 594 citations
Peers
Comparison fields: 5 of 66
- Toxicology 36
- Immunology 161
- Molecular Biology 477
- Endocrinology, Diabetes and Metabolism 81
- Physiology 102
Countries citing papers authored by Jill E. Clampit
This map shows the geographic impact of Jill E. Clampit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill E. Clampit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill E. Clampit more than expected).
Fields of papers citing papers by Jill E. Clampit
This network shows the impact of papers produced by Jill E. Clampit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill E. Clampit. The network helps show where Jill E. Clampit may publish in the future.
Co-authors
The 25 scholars most cited alongside Jill E. Clampit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 167 | |
| 2 | 2002 | 138 | |
| 3 | 2006 | 64 | |
| 4 | 2006 | 45 | |
| 5 | 2006 | 37 | |
| 6 | 2006 | 36 | |
| 7 | 2003 | 33 | |
| 8 | 2003 | 33 | |
| 9 | 2006 | 24 | |
| 10 | 2006 | 15 | |
| 11 | 2001 | 10 | |
| 12 | 2004 | 6 | |
| 13 | 2003 | 4 | |
| 14 | Treatment of zucker diabetic fatty rats with antisense oligonucleotide to phosphotyrosine phosphatase-1B for 5 weeks halts development of diabetes | 2001 | 4 |
About Jill E. Clampit
Jill E. Clampit is a scholar working on Molecular Biology, Immunology, Organic Chemistry, Oncology and Endocrinology, Diabetes and Metabolism, having authored 14 papers that have together received 616 indexed citations. Recurring topics across this work include Protein Tyrosine Phosphatases (8 papers), Galectins and Cancer Biology (4 papers), Metabolism, Diabetes, and Cancer (4 papers), Melanoma and MAPK Pathways (3 papers), Synthesis and biological activity (3 papers), Diet, Metabolism, and Disease (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Quinazolinone synthesis and applications (2 papers). The work is most often cited by research in Toxicology (36 citations), Immunology (161 citations), Molecular Biology (477 citations), Endocrinology, Diabetes and Metabolism (81 citations) and Physiology (102 citations). Jill E. Clampit has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Cristina M. Rondinone, James M. Trevillyan, Rebecca J. Gum, Michael R. Jirousek, Bradley A. Zinker, Roger G. Ulrich, Leigh Frost, Paul Kroeger, Matthew Heindel and Sandra Koterski. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Biochemical and Biophysical Research Communications, Diabetes, SLAS DISCOVERY and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.